Orchid Pharma Limited (ORCHPHARMA) Financial History

Name: Orchid Pharma Limited (ORCHPHARMA) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - Specialty & Generic · DATA UPDATED 2026-09-20

Orchid Pharma Limited (ORCHPHARMA) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Chennai, India with about 1,169 employees. Its market capitalization is roughly ₹50 billion. In the fiscal year ended 2026-03-31, ORCHPHARMA reported ₹12.2B in revenue and ₹100M in net income.

Orchid Pharma Limited, a pharmaceutical company, engages in the development, manufacture, and marketing of active pharmaceutical ingredients, bulk actives, finished dosage formulations, and nutraceuticals in India.

Interactive charts & full statements →

ORCHPHARMA Revenue & Earnings History — Annual Income Statement

Income statement	2026-03-31	2025-03-31	2024-03-31	2023-03-31
Total Revenue	₹12.2B	₹13.9B	₹8.2B	₹6.7B
Gross Profit	₹3.6B	₹4.7B	₹3.2B	₹2.7B
Operating Income (EBIT)	₹408M	₹1.3B	₹785M	₹297M
Net Income	₹100M	₹1.4B	₹922M	₹463M

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ORCHPHARMA Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Total Revenue	₹3.0B	₹2.4B	₹2.1B	₹1.9B	₹2.6B
Gross Profit	₹999M	₹862M	₹641M	₹610M	₹798M
Operating Income (EBIT)	₹30M	₹565M	₹310M	(₹104M)	(₹162M)
Net Income	₹32M	₹238M	(₹126M)	(₹57M)	(₹57M)

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ORCHPHARMA Free Cash Flow History

ORCHPHARMA Balance Sheet History

Balance sheet	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Total Assets	₹22.6B	₹20.8B	₹15.5B	₹12.3B	—
Total Liabilities	₹6.9B	₹5.2B	₹3.8B	₹5.4B	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive ORCHPHARMA viewer.

Other Companies in Drug Manufacturers - Specialty & Generic

IOLCP · IOL Chemicals and Pharmaceuticals Limited — ₹60 billion
FDC · FDC Limited — ₹57 billion
GUJTHEM · Gujarat Themis Biosyn Limited — ₹56 billion
NOVARTIND · Novartis India Limited — ₹51 billion
4554 · Fuji Pharma Co., Ltd. — JPY 49 billion
RPGLIFE · RPG Life Sciences Limited — ₹46 billion
2196 · Shanghai Fosun Pharmaceutical (Group) Co., Ltd. — HK$46 billion
GUFICBIO · Gufic Biosciences Limited — ₹44 billion

← ORCHASP All “O” companies ORCL →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.